This study underscores the cost-effectiveness and public health significance of AI-driven screening, demonstrating its potential to improve early detection and address unmet diagnostic needs in osteoporosis care.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Acute non-hypersensitivity adverse reactions following intravascular administration of contrast agents in adult patients
An adverse drug reaction (ADR) following intravascular administration of contrast agents (CA), including iodine-based contrast media (ICM), gadolinium-based contrast agents (GBCA), or ultrasound contrast agents (USCA), is defined as a harmful and unintended response to a CA. In this context, ‘response’ implies that a causal relationship between a medicinal product and an adverse event is at least a reasonable possibility [1].
-
The effect of metoprolol on heart rate before coronary CT angiography: Lessons and recommendations from a large cohort
Coronary CT angiography (CCTA) is the recommended initial test for most patients with suspected coronary artery disease (CAD).1 In preparation for CCTA, lowering the heart rate (HR) is essential to optimize image quality, reduce radiation exposure, and enable advanced techniques such as CT-derived fractional flow reserve – even with modern CT scanners.2–4 A target HR of <60 beats per minute (bpm) during CCTA is recommended for commonly used scanners, primarily to minimize motion-related artif…
-
Intravenous metoprolol and diltiazem drug combination therapy for heart rate control in coronary CT angiograms
Heart rate control by metoprolol yields better image quality for CT coronary angiograms (CTCA). When metoprolol fails to satisfactorily reduce heart rate, drug combinations can be used. The safety profile of combining metoprolol and diltiazem for CTCA is unknown but known risks include atrioventricular nodal block, bradycardia, hypotension and heart failure.1,2
-
New Lantern Unveils AI-Powered PET/CT and Mammography Viewers
Combining sub-second load times and AI-automated features, the PET/CT Viewer Mode and Mammography Viewer Mode may help address bottlenecks in nuclear medicine imaging and mammography workflows.
-
Rodman: AI Will Impact Oncology More Than Primary Care
Rodman predicts that specialties with more cognitive work, such as prescribing chemo drugs, rather than patient relationships or procedures will be automated first. Medscape
-
MRI-Based Deep Learning Model Bolsters Prediction of PI-RADS 3 and 4 Lesions
Offering an 87 percent sensitivity for clinically significant prostate cancer (csPCa), the deep learning model demonstrated an 86 percent AUC for predicting > PI-RADS 3 lesions on prostate MRI.
-
Mammography and PET/CT Viewers Added to New Lantern's AI Radiology Platform
tim.hodson
Tue, 08/05/2025 – 13:49
Aug. 5, 2025 — New Lantern has announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET/CT Viewer Mode. These solutions address bottlenecks in breast imaging and breast and PET/CT imaging, delivering sub-second load times and AI-powered automation, called Curie, to all imaging modalities. With these additions, the company now serves the full spectrum of imaging modalities, delivering a complete AI radiology solutio…
-
Fewer Black women may be eligible for supplemental imaging for dense breasts
The findings suggest that insurance coverage policies for supplemental screening ‘may have limited ability to improve early detection…
-
MRI shows promise profiling hepatocellular carcinoma tumors
A study suggests that imaging-based screening with targeted pathological workup could help refine treatment strategies.